TYENNE
TYENNE
Approved
DIN Number
02552493
Drug Class
Human
Market Date
Apr 14, 2025
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02552493
AIG Number0152713002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC07 TOCILIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
TOCILIZUMABActive
Strength: 162 MG / 0.9 ML
Monograph: TOCILIZUMAB